Credit: JLabs @ Toronto
Boston-based biotech Advanced Proteome Therapeutics (CVE:APC) said today that it is moving into Johnson & Johnson‘s (NYSE:JNJ) Innovation lab, JLabs, in Toronto.
The 40,000 square-foot incubator is home to a number of life science start-up companies, including Avrobio and Immune Biosolutions. Johnson & Johnson Innovation doesn’t take an equity stake in the companies occupying its lab space, but the start-ups can initiate external partnerships with Johnson & Johnson or other companies.
Get the full story at our sister site, Drug Delivery Business News.
The post Advanced Proteome Therapeutics moves into Johnson & Johnson’s Innovation lab appeared first on MassDevice.